Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to produce and sell Oxcarbazepine tablets in strengths of 150 mg, 300 mg, and 600 mg. Oxcarbazepine tablets is the generic of Trileptal Tablets, a drug commonly used to treat seizure disorders like epilepsy. This significant approval allows Zydus Lifesciences to […]
Indoco Remedies, an Indian pharmaceutical company, has obtained the European Union (EU) Good Manufacturing Practice (GMP) certification from the Competent Health Authority of Germany. The certification applies to Indoco Remedies’ manufacturing site located at Katha village in Baddi, Nalagarh tehsil in the Solan district, Himachal Pradesh. This recognition follows a rigorous inspection conducted by the […]
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the United States Food and Drug Administration (FDA). According to Zydus Lifesciences, Sildenafil for oral suspension is approved for the treatment of high blood pressure in the lungs (pulmonary hypertension). By […]
ANG Lifesciences India said that it has acquired two formulation manufacturing facilities in Baddi, Himachal Pradesh from Ind-Swift Limited for INR 60 crores. The acquired plants are now operating as Unit 5 and Unit 6 of ANG Lifesciences India and will help scale the company’s manufacturing capacity to handle the increasing demand from the domestic […]
Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) and Indian vaccine and pharma manufacturer Panacea Biotec have launched production of the Sputnik V Covid vaccine in India. According to RDIF, the first batch of the Sputnik V vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to the […]